Enhancement of Ad-p53 therapy with docetaxel in head and neck cancer. [electronic resource]
Producer: 20050203Description: 1871-9 p. digitalISSN:- 0023-852X
- Animals
- Antineoplastic Agents, Phytogenic -- therapeutic use
- Apoptosis -- drug effects
- Bridged-Ring Compounds -- pharmacology
- Carcinoma, Squamous Cell -- therapy
- Cell Line, Tumor
- Combined Modality Therapy
- Docetaxel
- Enterovirus -- drug effects
- Genetic Therapy -- methods
- Head and Neck Neoplasms -- therapy
- Humans
- Mice
- Mice, Inbred BALB C
- Protein Biosynthesis -- drug effects
- Taxoids -- pharmacology
- Transduction, Genetic
- Tumor Suppressor Protein p53 -- biosynthesis
No physical items for this record
Publication Type: Journal Article; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, P.H.S.
There are no comments on this title.
Log in to your account to post a comment.